Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

441.70 -2.58 (-0.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,459,449
Open 444.15
Bid (Size) 436.30 (40)
Ask (Size) 445.00 (80)
Prev. Close 444.28
Today's Range 437.19 - 447.82
52wk Range 362.50 - 510.77
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong. ↗
Could the White House be overly optimistic about inflation? If so, you may want to own these stocks. 
Via The Motley Fool
Topics Economy Government
News headline image
Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position? ↗
With an approved treatment in commercial stages and new drug candidates generating clinical trial results, this biotech has attracted a big Investor. 
Via The Motley Fool
Topics ETFs

Performance

YTD
-2.3%
-2.3%
1 Month
-5.2%
-5.2%
3 Month
-2.9%
-2.9%
6 Month
+7.2%
+7.2%
1 Year
-10.9%
-10.9%

More News

Read More
News headline image
Vertex to Announce First Quarter 2026 Financial Results on May 4th
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Growth and Technical Setup ↗
Via Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investment ↗
Via Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Merges Strong Fundamentals with Bullish Technical Setup ↗
Via Chartmill
News headline image
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
Via StockStory
News headline image
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Biotech Defies Gravity: Sarepta and Corcept Lead Midday Healthcare Rally Amidst Market Volatility
Via MarketMinute
Topics Economy Intellectual Property Stocks
News headline image
1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down
Via StockStory
News headline image
Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise Anyway ↗
Via The Motley Fool
Topics Economy Energy Government
News headline image
2 Stocks I Plan to Hold for the Next 20 Years ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
Via StockStory
News headline image
Where Will Vertex Pharmaceuticals Be in 1 Year? ↗
Via The Motley Fool
News headline image
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? ↗
Via The Motley Fool
News headline image
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
Via ACCESS Newswire
News headline image
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
Via Finterra
Topics Intellectual Property
News headline image
Is CRISPR Therapeutics Stock a Buy Now? ↗
Via The Motley Fool
News headline image
My Top 3 Drug Stocks for March 2026 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
1 Momentum Stock to Research Further and 2 We Ignore
Via StockStory
News headline image
Is Vertex Pharmaceuticals Heading to $600? ↗
Via The Motley Fool
News headline image
This Stock Just Jumped By 8%: Is It Too Late to Buy? ↗
Via The Motley Fool
News headline image
2 Reasons to Watch VRTX and 1 to Stay Cautious
Via StockStory
Topics Stocks

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 441.70
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 04/15/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 114.59B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 115B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.